 |
|

Dr. Chang's Publications at University of
Rochester Period (1997-2007)
|
 |
Choose Publication Period:
-
Lin M-F, Meng T-C,
Roa PS, Chang C, Schonthal AH, and Lin F-F (1998) "Expression
of human prostatic acid phosphatase correlates with androgen-stimulated
cell proliferation in prostate cancer cell lines." J. Biol. Chem.
273, 5939-5947.
-
Uemura H and Chang
C (1998) "Antisense TR3 orphan receptor can increase prostate
cancer cell viability with Etoposide treatment." Endocrinology
139, 2329-2334.
-
Lin D-L Wu S-Q,
and Chang C (1998) "The genomic structure and chromosomal
location of the human TR2 orphan receptor: a member of steroid
receptor superfamily." Endocrine 8, 123-134.
-
Lee Y-F, Young W-J,
Burbach JPH and Chang C (1998) "Negative feedback control
of the retinoid-retinoic acid/retinoid X receptor pathway by the
human TR4 orphan receptor: a member of steroid receptor superfamily."
J. Biol. Chem. 273, 13437-13443.
-
Yeh S, Miyamoto
H, Shima H and Chang C (1998) "From estrogen to androgen
receptor: a new pathway for sex hormone in prostate." Proc. Natl.
Acad. Sci. 95, 5527-5532.
-
Miyamoto H, Yeh S,
Wilding G, and Chang C (1998) "Promotion of agonist activity
of antiandrogens by the androgen receptor coactivator, ARA70,
in human prostate cancer DU145 cells." Proc. Natl. Acad. Sci.
95, 7379-7384.
-
Huang S-B, Burbach
JPH and Chang C, (1998) "TR4 orphan receptor crosstalks
to chicken ovalbumin upstream protein-transcription factor and
thyroid hormone receptor to induce the transcriptional activity
of the human immunodeficiency virus type-1 long terminal repeat."
Endocrine, 8, 169-175.
-
Su C, Chong K, Dillmann
W, Chang C, Owen O, and Lai C (1998) "Constitutive and
inducible hsps70s are involved in oxidative resistance evoked
by heat shock or ethanol" J. Mol. Cell Cardiology. 30, 587-598.
-
Chong K-Y, Lai C-C,
Lilly S, Chang C, and Su C-Y (1998) "Stable overexpression
of the constitutive form of heat shock protein 70 confers oxidative
protection." J. Mol. Cell Cardiol. 30, 599-608.
-
Miyamoto H, Yeh S,
Huang S-B, Fugimoto N, Hsiao P, Ting H, Inui S, Nishimura K, Wang
C, Uemura H, Kang H, and Chang C (1998) "The Androgen Receptor
Coregulator ARA70" in Molecular Basis of Sex Hormone Receptor
Function (Gronemeyer H, Fugymann U and Parczyk ed) pp. 43-51,
Springer, Berlin.
-
Young W-J, Lee Y-F,
Smith SM, and Chang C (1998) "A bi-directional regulation
between the TR2/TR4 orphan receptors (TR2/TR4) and the ciliary
neurotrophic factor (CNFT) signaling pathway." J. Biol. Chem.
273, 20877-20885.
-
Chen X, Zachar V,
Chang C, Ebbesen P, and Liu X (1998) Differential expression
of Nur77 family members in human T-lymphotropic virus type 1-infected
cells: transactivation of the TR3/Nur77 gene by Tax protein."
J. Of Virology. 72, 6902-6906
-
Young W-J and Chang
C (1998) "Ontogeny and autoregulation of androgen receptor
mRNA expression in the nervous system." Endocrine 9, 79-88.
-
Chang C and
Pan, H-J (1998) "Thyroid hormone direct repeat 4 response element
is a positive regulatory element for the human TR2 orphan receptor,
a member of the steroid receptor superfamily." Mol. Cel. Biochem.
189, 195-200.
-
Mu X. Young W-J,
Liu Y-X, Uemura H, and Chang C (1998) "Induction of an
intronic enhancer of the human ciliary neurotrophic factor receptor
(CNTFRa) gene by the TR3 orphan receptor" " Endocrine 9, 27-32.
-
Pan H-J, Wilding
G, Uno H, Inui S, Goldsmith L, Messing E, and Chang C (1998)
"Evaluation of RU58841 as an antiandrogen in prostate PC3 cells
and a topical anti-alopecia agent in the bald scalp of Stumptailed
Macaques." Endocrine 9, 39-43.
-
Yeh S, Miyamoto
H, Nishimura K, Kang H, Ludlow J, Hsiao P, Wang C, Su C, and Chang
C (1998) "Retinoblastoma, a tumor suppressor, is a coactivator
for the androgen receptor in human prostate cancer DU145 cells."
Biomed. Biophysic. Res. Commun. 248, 361-367.
-
Jarrard DF, Kinoshita
H, Shi Y, Sandefur C, Hoff D, Meisner LF Chang C Herman
JG, Isaacs WB, and Nassif N (1998) "Methylation of the androgen
receptor promoter CpG island is associated with loss of androgen
receptor expression in prostate cancer cells." Cancer Research
58, 5310-5314.
-
Cardillo MR, Petrangeli
E, Aliotta N, Salvatori L, Ravenna L, Chang C, and Castagna
G (1998) "Androgen receptors in ovarian tumors: correlation with
Oestrogen and progesterone receptors in an immunohistochemical
and semiquantitative image analysis study." J. Exp. Clin. Cancer
Res. 17.2, 231-237.
-
Miyamoto H, Yeh
S, Lardy H, Messing E, and Chang C (1998) "Delta5-Androstenediol
is a natural hormone with androgenic activity in human prostate
cancer cells." Proc. Natl. Acad. Sci.19, 11083-11088.
-
Cardillo MR, Petrangeli
E, Ravenna L, Salvatori L, Chang C, DiSilverio F (1998)
"Immunohistochemical quantification and determination of Cathepsin
D in prostatic neoplasia: correlation with steroid". Applied Immunohistochemistry
6(3), 133-139.
-
Kang H-Y, Yeh S,
Fujimoto N, and Chang C (1999) "Cloning and characterization
of human prostate coactivator, ARA54, a novel protein that associates
with the androgen receptor." J. Biol. Chem. 274, 8570-8576.
-
Mu XM, Liu YX and
Chang C (1998) "Mechanism of the interaction between orphan
receptor TR3 and cis-acting element in CNTFRa gene." Chinese J.
Biochemistry and Molecular Biology 14, 484-492.
-
Yeh S, Chang H,
Miyamoto H, Takatera H, Rahman M, Kang H, Thin T, Lin D, and
Chang C (1999) "Differential induction of androgen receptor
transcriptional activity by selective androgen receptor coactivators."
Keio J. of Medicine 48, 87-92.
-
Wang C, Young W-J,
and Chang C (1999) "Androgen effects on the solubility
and conformational change of androgen receptor in baculovirus
expression system." Mol. Cel. Biochem. 195, 19-23.
-
Inui, S, Lee Y-F,
Haake AR, Goldsmith LA, and Chang C (1999) "Induction of
TR4 orphan receptor by retinoic acid in human HaCaT keratinocytes"
in: Journal of Investigative Dermatology 112, 426-431.
-
Heinlein CA, Ting
H-J, Yeh S and Chang C (1999) "Identification of ARA70
as a ligand-enhanced coactivator for the peroxisome proliferator-activated
receptor gamma." J. Biol. Chem 274, 16147-16152.
-
Yeh S, Lin H-K,
Kang H-Y, Thin TH, Lin M-F, and Chang C (1999) "From HER2/Neu
signal cascade to androgen receptor and its coactivators: a novel
pathway by induction of androgen target genes through MAP kinase
in prostate cancer cells." Proc. Natl. Acad. Sci. 96, 5458-5463.
-
Lee H-J, Lee Y-F,
and Chang C (1999) "Identification of the histamine H1
receptor gene as a differentially repressed target of the human
TR2 orphan receptor." Mol. Cel. Biochem. 194, 199-207.
-
Lee Y-F. Young W-J,
Lin W-J, Shyr C-R, and Chang C (1999) "Differential regulation
of direct repeat 3 Vitamin D3 and direct repeat 4 thyroid hormone
signaling pathways by the human TR4 orphan receptor." J. Biol.
Chem. 274, 16198-16205.
-
Hsiao P and Chang
C (1999) "Isolation and characterization of ARA160 as an androgen
receptor N-terminal associated coactivator in human prostate cells."
JBC 274, 22373-22379.
-
Hsiao P, Lin D,
Nakao K, and Chang C (1999) "The linkage of the KennedyÕs
neuron disease to ARA24, the first identified androgen receptor
poly-glutamine region-associated coactivator." J. Biol. Chem.
274, 20229-20234.
-
Yang C, Yeh S, Leskov
K, Odegaard E, Hsu H, Chang C Kinsella T, Cheb D, and Boothman
D (1999) "Isolation of Ku70-binding proteins (KUBs)." Nucleic
Acid Res.27, 2165-2174.
-
Fujimoto N, Yeh S,
Kang H-Y, Inui S, Chang H-C, Mizokami A, and Chang C (1999)
"Cloning and characterization of androgen receptor coactivator,
ARA55, in human prostate." J. Biol. Chem 274, 8316-8321.
-
Lee Y, Shyr C, Thin
T, and Chang C (1999) "Convergence of two repressors through
heterodimer formation of androgen receptor and TR4 orphan nuclear
receptor: a new signaling pathway in the steroid receptor superfamily."
Proc. Natl. Acad. Sci. 96, 14724-14729.
-
Shih C, Young W,
Wang C, Jin L, Ji X, Guan Q, Wang M, and Chang C (1999)
"Monoclonal anti-androgen receptor antibodies: production, characterization
and potential diagnostic applications. " Mol. Cel. Biochem. 201,
131-140.
-
Kameoka Sei, Leavitt
P, Chang C, and Kuo SM (1999) "Expression of antioxidant
proteins in human intestinal Caco-2 cells treated with dietary
flavonoids." Cancer Letters 146, 161-167.
-
Yeh S, Kang H, Miyamoto
H, Nishimura K, Chang H, Fujimoto N, Ting H, Mizokami A, Huang
K, and Chang C (1999) "Differential induction of androgen
receptor transactivation by different androgen receptor coactivators
in human prostate DU145 cells." Endocrine 11, 195-202.
-
Chang HC, Miyamoto
H, Yeh S, Lardy H, and Chang C (1999) "Suppression of Delta5-Androstenediol-induced
AR transactivation by selective steroids in human prostate cancer
cells " Proc. Natl. Acad. Sci 96, 11173-11177.
-
Pan H, Uno H, Obana
N, and Chang C (1999) "The roles of testosterone in the
growth of keratinocytes through bald frontal dermal papilla cells."
Endocrine 11, 321-327.
-
Liu X, Chen X, Zachar
V, Chang C, and Ebbesen P (1999) "Transcriptional activation
of human TR3/nur77 gene expression by human T-lymphotropic Virus
type I Tax protein through two AP-1-like elements" J. of General
Virology 80, 3073-3081.
-
Miyamoto H and Chang
C (2000) "Antiandrogens fail to block completely the androstenedione-induced
mutated androgen receptor transactivation in human prostate cancer
cells." International J. Urology. 7, 32-34.
-
Inui S, Itami S,
Pan H, and Chang C (2000) "Lack of androgen receptor transcriptional
activity in human keratinocytes." J. Dermatological Science 23,
87-92.
-
Nishimura K, Sampson
E, Yan S, Kim E, Wang X, Uemura H, Wang C, Fujimoto N, Kang H,
Yeh S, and Chang C (2000) "Yeast two-hybrid screening of
associated proteins and characterization of mutant androgen receptors."
329-343 in Yeast Hybrid Technologies. (Zhu L and Hannon G ed).
Eaton Publishing.
-
Lin D and Chang
C (2000) "Identification and characterization of an essential
cis-acting element (TR2-PACE) in the 5Õ promoter of human TR2
orphan nuclear receptor gene" Endocrine 12, 89-97.
-
Hsiao P, Thin T,
Lin D and Chang C (2000) "Differential regulation of testosterone
vs 5a-dihydrotestosterone by selective androgen response elements"
" Mol. Cel. Biochem. 206, 169-175.
-
Wang C, Young W and
Chang C (2000) "Isolation and characterization of androgen
receptor mutants with divergent transcriptional activity in response
to hydroxyflutamide." Endocrine 12, 69-76.
-
Lee K, Duo J, Hsiao
P, and Chang C (2000) " From androgen receptor to general
transcription factor TFIIH: Identification of cdk Activating Kinase
as an AR N-terminal associated coactivator." J. Biol. Chem. 275,
9308-9313.
-
Hsing A, Gao Y, Wu
G, Chen Y, Deng j, Sesterhenn I, Mostofi F and Chang C
(2000) "Polymorphic CAG/CAA repeat length in the androgen receptor
gene and prostate cancer risk: a population-based case-control
study in china" Cancer Research 60, 5111-5116.
-
Yeh S, Hu Y, Rahman
M, Lin H, Ting H, Kang H, and Chang C (2000) "Increase
of androgen-induced cell death and androgen receptor transactivation
by BRCA1 in prostate cancer cells." PNAS 97, 11256-11261.
-
Yeh S, Sampson E,
Lee OK, Kim E, Hsu C, Chen Y, Chang T, Altuwaijri S, Huang K,
and Chang C (2000) "Functional analysis of N-terminal and
Ligand-binding domain of androgen receptor coactivators in prostate
cancer." J. Formosan Medical Association 99, 885-894.
-
Schaick H, Rosmalen
J, Silva S, Chang C and Burbach P (2000) "Expression of
the orphan receptor TR4 during brain development of the rat" Mol.
Brain Res. 77, 104-110.
-
Mu X, Liu Y, Collins
L, Kim E and Chang C (2000) "The p53/Rb-mediated repression
of testicular orphan receptor-2 in the rhesus monkey with crytorchidism."
J. Biol. Chem. 275, 23877-23883.
-
Kinoshita H, Shi
Y, Sandefur C, Meisner L, Chang C, Choon A, Reznikoff C,
Bova S, Friedel A, and Jarrard D (2000) "Methylation of the androgen
receptor minimal promoter silences transcription in human prostate
cancer." Cancer Research 60, 3623-3630.
-
Kang HY, Lin HK,
Hu YC, Yeh S, Huang KE and Chang C (2001) "From TGF-b signaling
to androgen action: Identification of Smad3 as an androgen receptor
coregulator in prostate cancer cells" Proc. Natl. Acad. Sci. 98,
3018-3023.
-
Lee DK, Duan HO
and Chang C (2001) "Androgen receptor interacts with the
positive elongation factor P-TEFb and enhances the efficiency
of transcriptional elongation" J. Biol. Chem 276, 9978-9984.
-
Lin H, Yeh S, Kang
H. and Chang C (2001) "Akt suppresses androgen-induced
apoptosis by phosphorylatiing and inhibiting androgen receptor."
Proc. Natl. Acad. Sci 98, 7200-7205.
-
Heinlein CA and
Chang C (2001) "The role of chaperones in the nuclear translocation
and transactivation of steroid receptors" Endocrine 14, 143-149.
-
Mantalaris A, Panoskaltsis
N, Sakai Y, Bourne P, Messing E, Chang C, and Wu D (2001)
"Localization of androgen receptor expression in human bone marrow."
J. Pathology 193, 361-366.
-
Si M, AI-Sharafi
B, Lai C, Khardori R, Chang C, and Su C. (2001) "Gender
difference in cytoprotection induced by estrogen on female and
male bovine aortic endothelial cells." Endocrine 15, 255-262.
-
Sampson E, Yeh S,
Chang H, Tsai M, Wang X, Ting H-J, and Chang C (2001) "Identification
and characterization of androgen receptor associated coregulators
in prostate cancer cells." J. Biological Regulation & Homeostatic
Agents 15, 123-129.
-
Collins L, Lin D,
Mu X, and Chang C (2001) "Feedback regulation between orphan
nuclear receptor TR2 and human papilloma virus type 16." J. Biol.
Chem. 276, 27316-27321.
-
Lee HJ, Lee YF, and
Chang C (2001) "TR4 orphan receptor represses the human
steroid 21-hydroxylase gene expression through the monomeric AGGTCA
motif." Biochem. Biophys. Res. Commun. 285, 1361-1368.
-
Wang X, Yeh S, Wu
G, Hsu C, Wang L, and Chang C (2001) "Cloning and characterization
of androgen receptor coregulator, ARA267-a in prostate cancer
cells." J. Biol. Chem. 276, 40417-40423.
-
Kuo SM, Huang CT,
Blum PB, and Chang C (2001) "Quercetin cumulatively enhances
copper induction of metallothionein in intestinal cells." Bio.Trace
Element Res. 84, 1-10.
-
Inui S, Nakajima
T, Fukuzato Y, Fujimoto N, Chang C, Yoshikawa K, Itami
S (2001) "Potential anti-androgenic activity of roxithromycin
in skin. "J Dermatol Sci. 27 (2):147-51.
-
Heinlein C and Chang
C (2002)ÔStructural and Functional Analysis of the Androgen
ReceptorÕ pp17-56 in Androgens and Androgen Receptor: Mechanisms,
Functions and Clinical Application. (Chang C ed).
-
Kluwer, USA. Li M,
Richter F, Chang C, Irwin RJ and Huang H.(2002)"Androgen
and retinoic acid interaction in LNCaP cells, effects on cell
proliferation and expression of retinoic acid receptors and epidermal
growth factor receptor" BMC Cancer 2:16-23.
-
Miyamoto H, Rahman
M, Takatera H, Kang H, Yeh S, Chang H, Nishimura K, Fujimoto N,
and Chang C (2002) "A dominant-negative mutant of androgen
receptor coregulator, ARA54 inhibits androgen receptor-mediated
prostate cancer growth." J. Biol. Chem. 277, 4609-4617.
-
Heinlein C and Chang
C (2002)ÔSignal Transduction Pathways Modulate Androgen Receptor
Transcriptional ActivityÕ pp 57-90 in Androgens and Androgen Receptor:
Mechanisms, Functions and Clinical Application. (Chang C ed).
Kluwer, USA.
-
Schinner S, Dellas
C, Schroder M, Heinlein C, Chang C, Fischer J and Knepel
W (2002) "Repression of glucagon gene transcription by PPARg through
inhibition of Pax6 transcriptional activity." J. Biol. Chem. 277,
1914-1948.
-
Shyr C, Hu YC, Kim
ES, and Chang C (2002) "Modulation of estrogen receptor-mediated
transactivation by orphan receptor TR4 in breast cancer MCF-7
cells." J. Biol. Chem. 277, 14622-14628.
-
Heinlein C, Sampson
E and Chang C (2002) ÔAndrogen Receptor Interacting Proteins
Co-Activators and Co-RepressorsÕ pp 91-138 in Androgens and Androgen
Receptor: Mechanisms, Functions and Clinical Application. (Chang
C ed).Kluwer, USA.
-
Ting H, Yeh S, Nishimura
K, and Chang C (2002) "Supervillin associated with androgen
receptor and modulates its transcriptional activity" Proc Natl.
Acad. Sci .99, 661-666.
-
Hsing A, Chokkalingam
A, Gao Y, Wu G, Wang X, Deng j, Cheng J, Sesterhenn I, Mostofi
F, Chiang T, Chen Y, Stanczyk F, and Chang C (2002) "Polymorphic
CAG/CAA repeat length in the A1B1/SRC-3 gene and prostate cancer
risk: a population-based case-control study." Cancer Epidemiology,
Biomakers and Prevention 11, 337-341.
-
Shyr C, Collins L,
Mu XM, Platt KA and Chang C (2002) "Spermatogenesis and
testes development are normal in mice lacking the testicular orphan
nuclear receptor-2 (TR2)." MCB. 22, 4661-4666.
-
Heinlein C and Chang
C (2002)ÔNongenomic Androgen ActionÕ 139-154 in Androgens
and Androgen Receptor: Mechanisms, Functions and Clinical Application.
(Chang C ed). Kluwer, USA.
-
Wang X, Yang Y, Guo
X, Sampson E, Hsu CL, Tsai MY, Wu G, Guo Y and Chang C
(2002) "Suppression of androgen receptor transactivation by Pyk2
via interaction and phosphorylation of the ARA55 coregulator J.
Biol. Chem. 277, 15426-15431.
-
Heinlein CA, and
Chang C (2002) "Androgen receptor coregulator: an overview"
Endocrine Review. 23, 175-200.
-
Lin HK, Wang L,
Hu YC, Altuwaijri S and Chang C (2002)"Phosphorylation-dependent
ubiquitination and degradation of AR by Akt requires Mdm2 E3 ligase"
EMBO 21, 1-12.
-
Fu M, Wang C, Wang
J, Zhang X, sakamaki T, Yeung YG, Chang C, Hopp T, Fuqua
S, Jaffray E, Hay RT, palvino JJ, Janne OA and Pestell R (2002)
"Androgen receptor acetylation governs transactivation and MEKK1-induced
apoptosis without affecting in vitro sumoylation and transrepression
function." MCB 15, 3373-3388.
-
Thin TH, Kim E, Yeh
S, Sampson ER, Chen YT, Collin L, Basavappa R, and Chang C
(2002) "Mutations in the helix 3 region of the androgen receptor
abrogate ARA70 promotion of 17b-estrodiol-induced androgen receptor
transactivation" J. Biol. Chem. 277, 36499-36508.
-
Hsing A, Culig Z,
Wang X, Uemura H and Chang C (2002) ÔThe Expanded Poly-Q
Length Within AR and AR Coregulator A1B1 And Their Clinical ImplicationsÕ
pp 245-264 in Androgens and Androgen Receptor: Mechanisms, Functions
and Clinical Application. (Chang C ed). Kluwer, USA.
-
Hu YC, Shyr CR, Che
S, Mu XM, Kim E and Chang C (2002) "Suppression of estrogen
receptor-mediated transcription and cell growth by interaction
with TR2 orphan receptor" J. Biol. Chem. 277, 33571-33579.
-
Collins L, Mu X and
Chang C (2002) ÔAndrogens in Spermatogenesis and ContraceptionÕ
pp 299-324 in Androgens and Androgen Receptor: Mechanisms, Functions
and Clinical Application. (Chang C ed). Kluwer, USA.
-
Lee Y, Lee H and
Chang C (2002) "Recent advances in the TR2 and TR4 orphan
receptors of nuclear receptor superfamily. JSBMB 1728, 1-17.
-
Sampson E, Yeh S.
Miyamoto H, Lee DK, Tsi, MY, Wang X, Hsu CL, and Chang C
(2002) "Interaction of cell cycle regulatory proteins with the
androgen receptor." pp 223-238 in Steroid hormones and cell cycle
regulation. (Burnstein KL ed). Kluwer, USA.
-
Lin HK, Hu YC, Altuwaijri
S and Chang C (2002) "Proteasome activity is required for
androgen receptor transcriptional activity via regulation of androgen
receptor nuclear translocation and interaction with coregulators
in prostate cancer cells." J. Biol. Chem. 277, 36570-36576.
-
Lee Y, Lin W, Huang
J, Messing E, C Kuo, Wilding G, and Chang C (2001) "Activation
of MAP kinase pathway by the antiandrogen hydroxyflutamide in
androgen receptor negative prostate cancer cells." Cancer Research
62, 6039-6044.
-
Itami S. Inui S,
Uno H, Pan H, Chang E, Takayasu S, Ye F, Imamura K, Seki T, Ideta
R, Aoki H, Adachi K, Price V, Kurata S, Collins L, Heinlein C
and Chang C (2002) "Androgens in Dermatology: Hair Loss,
Acne, and Other Diseases." pp 411-476 in Androgens and Androgen
Receptor: Mechanisms, Functions and Clinical Application. (Chang
C ed). Kluwer, USA.
-
Heinlein CA, and
Chang C (2002) "The roles of AR and androgen binding proteins
in nongenomic androgen actions." Mol. Endo. 16, 2181-2187.
-
Yeh S, Tsai MY,
Xu Q, Mu X, lardy H, Huang KE, Lin H, Yeh SD, Altuwaijrl S, Zhou
X, Xing L, Boyce B, Hung MC, Zhang S, Gan L and Chang C
(2002) "Generation and characterization of androgen receptor knockout
(ARKO) mice: an in vivo model for the study of androgen functions
in selective tissues." Proc Natl. Acad. Sci. 99,13498-13503.
-
Ohtsu H, Ishida
J, Nagai M, Wang H, Itokawa H, Su C, Shih C, Chiang T, Chang E,
Lee Y, Tsai M, Chang C and Lee K (2002) "Antitumor agents
217. Curcumin analogues as novel androgen receptor antagonists
with potential as anti-prostate cancer agents." J. of Medicinal
Chemistry 45, 5037-5042.
-
Shih C, Chang E,
Zhang Y, Lai C, Su C, Chen Y, Chang H, Chiang T and Chang C
(2002) "The use of a flow cytometry analysis in the study of different
expression of androgen receptor in human prostate cancer LNCaP
and PC-3 cells." New Taipei Journal of Medicine 4, 151-158.
-
Kang H, Huang KE,
Chang S, Ma WL, Lin WJ and Chang C (2002) "Differential
modulation of androgen receptor-mediated transactivation by Smad3
and tumor suppressor Smad4." J. Biol. Chem. 277, 43749-43756.
-
Lin J, Li J, Lee
YF, Yeh SD, Altuwaijri S, Ou JH and Chang C (2003) "Suppression
of hepatitis B virus core promoter by the nuclear orphan receptor
TR4." J. Biol. Chem. 278, 9353-9360.
-
Yang Y, Wang X, Dong
T, Kim E, Lin WJ and Chang C (2003) "Identification of
a novel TR4 orphan receptor associated protein (TRA16) as repressor
for the selective suppression of TR4-mediated transactivation."
J. Biol. Chem. 278, 7709-7717.
-
Lee DK and Chang
C (2003) "Molecular communication between androgen receptor
and general transcription machinery." JSBMB 84, 41-49.
-
Thin TH, Kim E, Basavappa
R, and Chang C (2003) "Isolation and characterization of
androgen receptor mutant, AR(M749L), with hypersensitivity to
the 17-beta estradiol treatment." J. Biol. Chem. 278, 7699-7708.
-
Rahman MM, Miyamoto
H, Takatera H, Yeh S, Altuwaijri S and Chang C (2003) "Reducing
the agonist activity of antiandrogens by a dominant-negative androgen
receptor coregulator ARA70 mutant in prostate cancer cells."J.
Biol. Chem. 278, 19619-19626
-
Rahman MM, Miyamoto
H, Kan PY, Lardy H and Chang C (2003) "Inactivation of
androgen receptor (AR) coregulator ARA55 leads to an inhibition
of AR transactivation and a reduction of the agonist activity
of antiandrogens in prostate cancer cells." Proc Natl. Acad. Sci.
100, 5124-5129
-
Lee DK, Li M and
Chang C (2003) "The second largest subunit of RNA polymerase
II interacts with and enhances transactivation of androgen receptor."
BBRC 302, 162-169.
-
Miyamoto H, Marwah
P, Lardy H and Chang C (2003) "3b-Acetoxyandrost-1,5-diene-17-ethylene
ketal functions as a potent antiandrogen with marginal agonist
activity." Proc Natl. Acad. Sci. 100, 4440-4444.
-
Yang L, Lin HK, Altuwaijri
S, Xie S and Chang C (2003) "APPL suppresses androgen receptor
transactivation via potentiating Akt activity." J. Biol. Chem.
278,16820-16827.
-
Hsu CL, Yeh S, Chen
YL, Ting HJ, Hu YC, Hank L, Wang X and Chang C (2003) "The
use of phase display technique for the isolation of androgen receptor
interacting peptides with F/WXXLF/W and FXXLY new signature motifs."
J. Biol. Chem. 278, 23691-23698.
-
Mu X, and Chang
C. (2003) "TR3 orphan nuclear receptor mediates apoptosis
through up-regulating E2F1 in human prostate cancer LNCaP cells".
J. Biol. Chem. 278, 42840-42845.
-
Kim E, Xie S, Lee
YF, Collins L, Hu YC, Shyr CR, Mu XM, Liu NC, Chen YT, Wang PH,
and Chang C (2003) "ApoE-TR4 orphan nuclear receptor induces
the expression of liver apolipoprotein E/C-I/C-II gene cluster
via hepatic control region." J. Biol. Chem. 278, 46919-46926.
-
Lee HJ, Sampson
ER, Hsu CL, Chen YT and Chang C (2003) "Androgen receptor."
pp 87-101 in Molecular mechanisms of action of steroid receptors
(Marija and Costas Demonacos ed). Research Signpost, India.
-
Chey WY, Chang CH,
Pan H, Chang C, Kim BK, Park IS and Chang TM (2003) "Evidence
on the presence of secretin cells in the gastric antral and oxyntic
mucosa." Regulatory Peptides 111, 183-190.
-
Yang L, Wang L, Lin
HK, Kan P, Xie S, Tsai MY, Wang PH, Chen YT and Chang C
(2003) "Interleukin-6 differentially regulates androgen receptor
transavtivation via PI3K-Akt, STAT3 and MAPK three distinct signal
pathways in prostate cancer cells." BBRC. 305, 462-469.
-
Lee H, and Chang
C (2003) "Recent advances in the androgen receptor action."
Cellular and Molecular Life Sciences. 60, 1613-1622.
-
Inui, S, Lee Y, Chang
E, Shyr CR and Chang C (2003) "Differential and bidirectional
regulation between TR2/TR4 orphan nuclear receptors and a specific
ligand mediated-peroxisome proliferator-activated receptor a (PPARa)
in human HaCaT keratinocytes." J. of Dermatology Science.31, 65-71.
-
Mu X and Chang
C (2003) "TR2 orphan receptor functions as negative modulator
for androgen receptor in prostate cancer cells PC-3." The Prostate.
57,129-133.
-
Heinlein CA, and
Chang C (2003) "Induction and Repression of Peroxisome
Proliferator-Activated Receptor alpha (PPARa) Transcription by
the Coregulator ARA70." Endocrine. 21, 139-146.
-
Cai Y, Dai T, Ao
Y, Konishi T, chuang KH, Lue Y, Chang C and Wan Y (2003)
"Cytochrome P450 gene are differentially expressed in female and
male hepatocyte retinoid X receptor a-deficient mice." Endocrinology
.144, 2311-2318.
-
Kang HY, Tsai MY,
Chang C and Huang KE (2003) "Mechanisms and clinical relevance
of androgens and androgen receptor action." Chang Gung Medical
J. 26, 388-402.
-
Lee DK and Chang
C. (2003) "Expression and Degradation of Androgen Receptor:
Mechanism and Clinical Implication." Journal of Clinical and Metabolism
of Endocrinology. 88, 4043-4954 .
-
Nishimura K, Ting
HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S,
Shin M, AozasaK, Okuyama A and Chang C (2003) "Modulation
of androgen receptor transactivation by gelsolin: A new identified
AR coregulator" Cancer Research. 63, 4888-4894.
-
Altuwaijri S, Lin
HK, Chuang KH, Yeh S, Hanchett L, Zhang Y, Tsai MT, Yang L, and
Chang C (2003) "Interruption of NFkB Signaling by Androgen
Receptor Facilitates TPA-induce apoptosis in an Androgen Sensitive
Prostate Cancer Cell Line." Cancer Research. 63, 7106-7112.
-
Fu M, rao M, Wang
C, sakamaki T, Wang J, Vizio DD, Zhang X, Albanese C, Balk S,
Chang C. Fan S, Rosen E, Palvimo J, Janne O, Muratoglu
S, Avantaggiati ML and Pestell RG (2003) "Acetylation of androgen
receptor enhances coactivator binding and promotes prostate cancer
cell growth." MCB. 23, 8563-8573.
-
Yeh S, Hu YC, Wang
PH, Xie C. Xu Q, Zhou X, Tsai MY, Dong Z, and Chang C.
(2003) "Abnormal mammary gland development and growth retardation
in breast cancer MCF7 cells and female mice lacking androgen receptor."
J. Experimental Medicine 198, 1899-1908.
-
Ohtsu H, Itokawa
H, Su CY, Shih C, Chiang T, Chang E, Lee YF, Chen YT, Chang
C, and Lee, KH. (2003) "Antitumor Agents 222. Synthesis and
Anti-androgen Activity of New Diarylheptanoids." Bioorg Med Chem.
17, 5083-5090.
-
Lin H, Hu W, Yang
L, Altuwaijri S, Chen YT Kang HY and Chang C (2003) "Suppression
vs induction of androgen receptor by the PI3K/Akt pathway in prostate
cancer LNCaP cells with different passage numbers." J. Biol. Chem
19, 50902-50907.
-
Collins L, Lee H,
Chen YT, Yeh S and Chang C. (2003) "Androgen receptor in
spermatogenesis" Cytogenetic and Genome Research 103, 289-301.
-
Miyamoto H, Rahman
MM and Chang C (2004) "Molecular basis for the antiandrogen
withdrawal symdrome" J. Cellular Biochemistry. 1, 3-12.
-
Wang PH and Chang
C. (2004) "Androgens and ovarian cancers" Eu. J. Gynaec. Oncol.
25, 157-163.
-
Zhang Y, Yang Y,
Yeh S and Chang C. (2004) "ARA67 functions as a repressor
to suppress androgen receptor transactivation." MCB. 24, 1044-1057.
-
Hu YC, Wang PH, Hu
YC, Yeh S, Xie C, Zhou X, Xu Q, Chao HT, Tsai MY, and Chang
C. (2004) "Reduced fertility and defective ovulation in female
mice lacking androgen receptor." Proc Natl. Acad. Sci. 101, 11209-11214.
-
Yang L, Yeh SD, Xie
S, Altuwaijri S, Ni J, Hu YC, Chen YT, Bao BY, Su CH and Chang
C (2004) "Androgen suppresses PML protein expression in prostate
cancer CWR22R cells" BBRC 314, 69-75.
-
Heinlein CA and
Chang C (2004) "Androgen receptor in prostate cancer." Endocrine
Reviews. 25, 276-308.
-
Rahman M, Miyamoto
H, and Chang C. (2004) "Androgen Receptor Coregulators
in Prostate Cancer Progression: Mechanisms and Clinical Implications."
Clinical Cancer Research.
-
Wang L, Hsu CL, Ni
J, Wang PH, Yeh S, Ken P and Chang C. (2004) "Human checkpoint
protein hRad9 functions as a negative coregulator to repress androgen
receptor transactivation in prostate cancer cells" MCB. 24, 2202-2213.
-
Litvinov I, Chang
C and Isaacs J. (2004) "Molecular characterization of commonly-used
human androgen receptor expression vector, pSG5-AR" The Prostate.
58, 319-324.
-
Miyamoto H, Messing
E and Chang C (2004) "Androgen Deprivation Therapy for
Prostate Cancer: Current Status and Future Prospects." The Prostate.
61, 332-353.
-
Chang C, Chen
YT, Yeh SD, Xu Q, Guillou F, and Yeh S (2004) "Infertility with
defective spermatogenesis and hypotestosteronemia in mice lacking
androgen receptor in Sertoli cells." Proc Natl. Acad. Sci. 101,
6876-6881.
-
Xie S, Lin HK, Ni
J, Wang L, Yang L, di SantÕAgnese PA, and Chang C (2004)
"Regulation of interleukin-6 mediated P13K activation and neurendocrine
diffrentiation by androgen signaling in prostate cancer LNCaP
cells." The Prostate. 60, 61-67.
-
Mu X, Liu NC, Chen
YT, Collins L, Kim E, Shyr CR, Lee YF and Chang C (2004)"Target
inactivation of TR4 orphan receptor delays and disrupts late meiotic
prophase and subsequent meiotic divisions of spermatogenesis"
MCB. 24, 5887-5899.
-
Wang L, Lin HK,
Hu YC, Mu X, Xie S, and Chang C (2004) "Glycogen Synthase
Kinase 3b Negatively Regulates Androgen Receptor-Dependent Transcription
and Cell Growth." JBC. 279, 32444-52.
-
Lin H, Hu W, Lee
K and Chang C (2004) "Suppression of androgen receptor
transactivation by PTEN tumor suppressor via protein degradation
and nuclear translocation." Mol. Endo. 18, 2409-2423.
-
Hu YC, Yeh S, Yeh
SD, Sampson E, Li P, Hsu CL, Ting H, Lin H, Wang L, Kim E and
Chang C (2004) "Functional Domain and Motif analyses of
androgen receptor coregulator ARA70 and its differential expression
in prostate cancer." JBC 279, 33438-46.
-
Ting HJ, Hu YC, and
Chang C (2004) "Actin monomer enhances supervillin-modulated
androgen receptor transactivation." BBRC 319,393-396.
-
Kang HY, Cho CL,
Wang JC, Hu YC, Lin HK, Chang C and Huang KE (2004) "Nongenomic
Androgen Activation of Phosphatidylinositol 3-Kinase/Akt Signaling
Pathway in MC3T3-E1 Osteoblasts." JBMR 19,1181-1190. (CC and HKE
are co-correspondence author)
-
Collins L, Lee YF,
Lin WJ, Heinlein CA, Liu NC, Chen YT, Chen Y, Shyr CR, Meshul
CK, Uno H, Chou S, Platt KA and Chang C (2004) "Growth
retardation and abnormal female maternity in mice lacking testicular
orphan nuclear receptor 4." PNAS. 101. 15058-15063.
-
Altuwaijri S, Lee
DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett
LA, Chang HC and Chang C (2004) "Androgen receptor regulates
expression of skeletal muscle specific proteins and muscle cell
types." Endocrine. 25(1):27-32.
-
Lee Y, Bao B and
Chang C (2004) "Modulation of the retinoic acid-induced
cell apoptosis and differentiation by the human TR4 orphan receptor."
BBRC. 323, 876-883.
-
Hsu CL, Chen YL,
Lin WJ, Yang Z, Zhang Y, Ting HJ, Wang L, Wu CT, Chang HC and
Chang C (2005) "Androgen receptor NH2- and COOH-terminal
interactions result in the differential influences on the AR-mediated
transactivation and cell growth."Mol Endo 19, 350-61.
-
Wang L, Hsu CL and
Chang C (2005) "Androgen receptor corepressors: an overview."
The Prostate 99, 1-14
-
Miyamoto H and Chang
C (2005) "Hormonal therapy for prostate cancer: clinical and
experimental evidence." pp 1-32. in Prostate Cancer: Basic Mechanisms
and Therapeutic Approaches. (Chang C ed). World Scientific. USA.
-
Kim E, Yang Z, Liu
B and Chang C (2005) "Induction of apolipoprotein E expression
by TR4 orphan nuclear receptor via 5' proximal promoter region."
BBRC. 328, 85-90.
-
Chen YT, Collins
LL, Uno H and Chang C (2005) "Deficits in Motor coordination
with Aberrant Cerebellar Development in Mice Lacking Testicular
Orphan Nuclear Receptor 4." MCB. 25, 2722-2732
-
Lin H, Xu Q, Yeh
S , Wang RS, Sparks JD and Chang C (2005) "Insulin and
leptin resistance with hyperleptinemia in mice lacking androgen
receptor." Diabetes.54, 1717-25.
-
Yang L, Xie S, Jamaluddin
MS, Altuwaijri S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang
KH, Wu CT, Chang C (2005) "Induction of Androgen Receptor
Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate,
FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer
Cells." JBC. 280(39):33558-65.
-
Chuang KH, Lee YF,
Lin WJ, Chu CY, Altuwaijri S, Wan YY and Chang C (2005)
"9-Cis-Retinoic Acid Inhibits Androgen Receptor Activity Through
Activation of Retinoid X Receptor." Mol Endo. 19(5):1200-1212.
-
Wu C, Yeh S, Xu Q,
Yang Z, Chang P, Yu Y, and Chang C (2005) "Study of androgen
receptor roles in prostate cancer using mice lacking functional
prostate androgen receptor" pp 223-238 in Prostate Cancer: Basic
Mechanisms and Therapeutic Approaches. (Chang C ed). World Scientific.
USA.
-
Miyamoto H, messing
E and Chang C (2005) "Does androgen deprivation therapy
improve treatment outcomes in patients with low- and intermediate-risk
prostate cancer" Nature Clinical Patrice: Oncology. 2. 236-237.
-
Miyamoto H, Altuwaijri
S, Cai Y, Messing E and Chang C (2005) "Inhibition of the
Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways
in combination with androgen deprivation therapy: Potential therapeutic
approaches for prostate cancer." Mol Carcinogen. 44(1):1-10.
-
Fujimoto N, Chang
C, Nomura M and Matsumoto T (2005) "Can we prevent prostate
cancer? Rationale and current status of prostate cancer chemoprevention."
Urol. Int. 74, 289-297.
-
Miyamoto H, Marwah
P, Marwah A, Yang Z, Chung CY , Altuwaijri1 S, Chang C
and Henry Lardy (2005) "Identification of steroid derivatives
that function as potent antiandrogens" Int. J. Cancer: 117, 866-872.
-
Mu X, Yang L, and
Chang C (2006) "Stage dependent and androgen inductive
expression of orphan receptor TR4 in rat testis." BBRC. 341, 464-469.
-
Marwah P, Marwah
A, Lardy H, Miyamoto H and Chang C (2006) "C19-Steroids
as androgen receptor modulators: Design, discovery, and structure-activity
relationship of new steroidal androgen receptor antagonists" Bioorganic
& Medical Chemistry. 14. 5933-5947.
-
Wang RS, Yeh S, Chen
LM, Lin HY, Zhang C, Ni J, Wu CC, di Sant'agnese PA, de Mesy-Bentley
KL, Tzeng CR, and Chang C (2006)" Androgen Receptor in
Sertoli Cell Is Essential For Germ Cell Nursery and Junctional
Complex Formation in Mouse Testes" Endocrinology. 147(12):5624
-5633
-
Tsai MY, Yeh SD,
Wang RS, Yeh S, Zhang C, Lin HY, Tseng CR and Chang C (2006)
"Differential Effects of Spermatogenesis and Fertility in Mice
Lacking Androgen Receptor in Individual Testis Cells" PNAS . 103(50):18975-80
-
Zhang C, Yeh S, Chen
YT, Wu CC, Chuang KH, Lin HY, Wang RS, Chang YJ, Mendis C, Hu
L, Lardy H and Chang C (2006) "Oligozoospermia with Normal
Fertility in Male Mice Lacking the Androgen Receptor in Testis
Peritubular Myoid Cells" PNAS. 103(47):17718-23.
-
Wang CP, Lee YF,
Chang C and Lee HJ (2006) "Transactivation of the proximal
promoter of human oxytocin gene by TR4 orphan receptor" BBRC.
351, 204 -208.
-
Yang Z, Chang YJ,
Miyamoto H, Ni J, Niu Y, Chen Z, Chen YL, Yao JL, SantAgnese
A and Chang C (2006) "Transgelin functions
as a suppressor via inhibition of ARA54-enhanced androgen receptor
transactivation and prostate cancer cell growth" Mol. Endo.
21(2): 343-58.
-
Yang Z, Chang YJ,
Miyamoto H, Yeh S, Yao YL, di SantÕAgnese PA, Tsai MY,and Chang
C (2006) ÒSuppression of androgen receptor transactivation
and prostate cancer cell growth by heterogeneous nuclear ribonuleoprotein
A1 via interaction with AR coregulator ARA54Ó Endocrinology. 148(3):1340-9.
-
Miyamoto H, Yang
Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Hu YC, Tsai MY, Yeh
S, Messing E and Chang C (2007) "Androgen Receptor Signals
Promote Bladder Cancer Development and Progression" JNCI, 99:
558-68.
-
Yang Z, Chang YJ,
Yu IC, Miyamoto H, Wu CC, Yeh S, Merry DE, Sobue G, Chen LM and
Chang C (2007) "ASC-J9 ameliorates spinal and bulbar muscular
atrophy phenotype via degradation of androgen receptor" Nature
Medicine 13(3):348-353. This Nature Medicine Paper got over
50-newspapers reporting and 2-TV-stations interviewing. Click
the following links to see those reports from English
newspaper, Chinese
newspaper and Taiwanese
newspaper.
-
Zhang Y, Chen YT,
Xie S, Wang L, Lee YF, Chang SS, and Chang C (2007)" Loss
of testicular orphan receptor 4 impairs normal myelination in
mouse forebrain" Mol. Endo. 21(4):908-20.
-
Altuwaijri S, Wu
CC, Niu YJ, Mizokami A, Chang HC, and Chang C (2007) "Expression
of human AR cDNA driven by its own promoter results in mild promotion,
but not suppression, of growth in human prostate cancer PC-3 cells"
AJA. 9(2):181-8.
-
Tanabe O, McPhee
D, Kobayashi S, Shen Y, Brandt W, Jiang X, Campbell AD, Chen YT,
Chang C, Yamamoto M, Tanimoto K, Engel JD. (2007) ÒEmbryonic
and fetal beta-globin gene repression by the orphan nuclear receptors,
TR2 and TR4Ó EMBO. 2;26(9):2295-306.
-
Zheng Y, Chen Kl,
Ma WL, Chang C, Ou JH (2007) "Enhancement of gene transactivation
activity of androgen receptor by hepatitis B virus X protein."
Virology, 5;363(2):454-61.
-
Yu SF, Cheng TT,
Hsu YH, Lai HM, Chen YC, Chiu CK, Lin KM, Chang C, Chen
CJ, Kang HY. (2007) "Association of tri-nucleotide (CAG and GGC)
repeat polymorphism of androgen receptor gene in Taiwanese women
with refractory or remission rheumatoid arthritis." Clin Rheumatol.
26(12):2051-8.
-
Wu CT, Altuwaijri
S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY , and Chang
C (2007) "Increased prostate cell proliferation and loss of
cell differentiation in mice lacking prostate epithelial androgen
receptor" PNAS . 104(31):12679-12684
-
Chen YT, Collins
LL, Uno H, Chou SM, Meshulf CK, Chang SS and Chang C (2007)
"Abnormal cerebellar cytoarchitecture and impaired inhibitory
signaling in adult mice lacking TR4 orphan nuclear receptor" Brain
Research, 1168:72-82.
-
Chen YT, Collins
LL, Chang SS, Chang C (2007) "The roles of testicular orphan
nuclear receptor 4 (TR4) in cerebellar development" Cerebellum,
5(4): 1-9.
-
Kim ES, Ma WL, Lin
DL, Inui S, Chen YL, and Chang C (2007) "TR4 orphan nuclear
receptor functions as an apoptosis modulator via regulation of
Bcl-2 gene expression". BBRC. 361(2):323-8.
-
Xu Q, Lin HY, Yeh
SD, Yu IC, Wang RS, Chen YT, Zhang C, Altuwaijri S, Chen LM, Chuang
KH, Chiang HS, Yeh S and Chang C. (2007) "Infertility
with defective spermatogenesis and steroidogenesis in male mice
lacking androgen receptor in Leydig cells." Endocrine 32:96Ð106.
-
Liu NC, Lin WJ, Kim
E, Collins LL, Lin HY, Yu IC, Sparks JD, Chen LM, Lee YF and
Chang C (2007) "Loss of TR4 Orphan Nuclear Receptor Reduces
Phosphoenolpyruvate Carboxykinase-Mediated Gluconeogenesis"
Diabetes 56:2901-2909.
-
Hamalainen-Laanaya
HK, Kobie JJ, Chang C and Zheng W (2007) "Temporal
and Spatial Changes of Histone 3 K4 Dimethylation at the IFN-Gene
during Th1 and Th2 Cell Differentiation" J. of Immunology
179: 6410-6415.
-
Zhao X, Zheng B,
Huang Y, Yang D, Katzman S, Chang C, Fowell D and Zheng
W (2007) "Interaction between GATA-3 and the Transcriptional
Coregulator Pias1 Is Important for the Regulation of Th2 Immune
Responses" J. of Immunology 179: 8297-8304.
-
Miyamoto H, Altuwaijri
S and Chang C (2008) "Androgen Receptor in Prostate
Cancer" pp 129-146 in Prostate Cancer: Signaling Networks,
Genetics, and New Treatment Strategies (Pestell R and Nevalainen
ed)
-
Chen LM, Wang RS,
Lee YF, Liu NC, Chang YJ, Wu CC, Xie S, Hung YC and Chang C.
(2008) "Subfertility with Defective Folliculogenesis in Female
Mice Lacking TR4 Orphan Nuclear Receptor" Mol Endo, 22(4):858-67.
-
Yu IC, Lin HY, Liu
NC, Wang RS, Sparks JD, Yeh S and Chang C. (2008) "Hyperleptinemia
without obesity in male mice lacking androgen receptor in adipose
tissue." Endocrinology. 149 (5): 2361-68.
-
Cai Y, Lee YF, Li
G, Liu S, Bao BY, Huang J, Hsu CL and Chang C. (2008) "A
new prostate cancer therapeutic approach: Combination of androgen
ablation with COX-2 inhibitor" Int J Cancer. 123, 195201.
-
Lin HY, Yu IC, Wang
RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks
JD, Yeh S and Chang C (2008) "Increased hepatic steatosis
and insulin resistance in mice lacking hepatic androgen receptor"
Hepatology, 47(6):1924-35.
(Click here to view all publications;
PDF files are available when you click indivudual publication)
|